Enovix (NASDAQ:ENVX) Price Target Cut to $5.50 by Analysts at TD Cowen
TD Cowen cut its Enovix (NASDAQ:ENVX) price target to $5.50 from $7.00 and kept a Hold rating, citing a potential upside of 37.67% versus the stock near $4.00. The article also notes other analyst target changes and that ENVX reported Q1 EPS of -$0.14 on revenue of $7.60M.
How this was made

The 30-second read
Why it matters
A lower price target with a Hold rating can shift near-term positioning and expectations, especially for a high-beta, loss-making stock where valuation is highly sentiment-driven.
Market read
Traders may reassess downside risk and near-term catalysts after a fresh sell-side target reduction, particularly given the stock’s recent weakness.
What to watch
The article includes prior guidance and financial ratios but does not connect TD Cowen’s cut to a specific new Enovix operational change, so the market may treat it as sentiment rather than a fundamental reset.
Background
The piece summarizes TD Cowen’s latest target change and lists other recent analyst rating/target moves for Enovix.
Ticker impact
TD Cowen cut Enovix’s price target from $7.00 to $5.50 and kept a Hold rating, implying reduced upside versus the prior view.
Short-term downside bias, with potential volatility around the new target and recent ~$4 print.
The article discloses a specific, dated sell-side target reduction (TD Cowen) plus the stock’s recent trading level, but it does not provide new company fundamentals beyond previously reported earnings and guidance.
Market effects
Reinforces cautious sentiment toward early-stage battery technology names, where valuation is sensitive to analyst target revisions.
Limited, as the catalyst is company-specific sell-side research rather than a macro/regional driver.
Low, no cross-border deal, regulation, or supply-chain event is described.
Counterpoint
Despite the TD Cowen cut, other analysts still rate ENVX Buy and the company recently reported revenue growth and beat on EPS versus consensus, which can offset target reductions.
Key entities
- companyEnovix
NASDAQ-listed lithium-ion battery cell developer whose price target was cut by TD Cowen.
- analyst_firmTD Cowen
Brokerage that reduced ENVX’s price objective from $7.00 to $5.50 and maintained a Hold rating.
